AstraZeneca To Present Abstracts On Influenza & Respiratory Syncytial Virus

By RTT News, 
A A A

AstraZeneca To Present Abstracts On Influenza & Respiratory Syncytial Virus


(RTTNews.com) - MedImmune Specialty Care division of AstraZeneca (AZN.L, AZN), (MedImmune Specialty Care), announced the presentation of 11 abstracts at the 2014 Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting. The company said these abstracts advance the body of existing data and knowledge around influenza and respiratory syncytial virus prevention, highlighting MedImmune Specialty Care's continued commitment to infectious disease and patient health.

MedImmune Specialty Care division of AstraZeneca is a patient-focused, biopharmaceutical business unit responsible for the commercialization of small molecule and biologic prescription medicines for AstraZeneca.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com



This article appears in: News Headlines

Referenced Stocks: AZN

RTT News


More from RTT News:

Related Videos

Stocks

Referenced

60%

Most Active by Volume

110,219,031
  • $6.79 ▲ 14.31%
104,982,008
  • $11.83 ▲ 12.35%
95,065,355
  • $3.40 ▲ 0.59%
79,694,763
  • $36.59 ▲ 2.64%
49,037,292
  • $39.90 ▲ 5.81%
47,069,528
  • $15.34 ▼ 1.03%
43,387,835
  • $6.56 ▼ 1.94%
42,066,487
  • $98.38 ▼ 0.65%
As of 7/29/2014, 04:04 PM